arrow
C

Cynthia A. Prows

universidad de extremadura
H指数:35
被引数:4,727

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6 Genotype and Use of 5-HT3 Receptor Antagonists: 2026 Update

CPIC临床药物基因组学实施联盟关于CYP2D6基因型与5-HT3受体拮抗剂使用的指南:2026年更新

2026-04-010
OAAI
Healthcare professionals’ experiences returning monogenic, polygenic, and integrated risk results in the eMERGE study

医疗专业人员返馈单基因、多基因和综合风险结果在eMERGE研究中的经验

2025-12-060
OAAI
Implementing integrated genomic risk assessments for breast cancer: lessons learned from the Electronic Medical Records and Genomics study

实施乳腺癌整合基因组风险评估:来自电子病历与基因组学研究(Electronic Medical Records and Genomics study)的经验教训

2025-10-010
PRE
Selection, optimization and validation of ten chronic disease polygenic risk scores for clinical implementation in diverse US populations

十种慢性病多基因风险评分的选择,优化和验证,以在美国不同人群中进行临床实施

2024-02-1924
OAAI
Prospective, multi-site study of healthcare utilization after actionable monogenic findings from clinical sequencing

临床测序可采取的单基因结果后医疗保健利用的前瞻性,多站点研究

2023-11-012
OAAI
Returning integrated genomic risk and clinical recommendations: The eMERGE study

回归综合基因组风险和临床建议: eMERGE研究

2023-04-0145
OAAI
The Reckoning: The Return of Genomic Results to 1444 Participants Across the eMERGE3 Network

清算: 通过eMERGE3网络将基因组结果返回给1444参与者

2022-11-010
PRE
Multiancestral polygenic risk score for pediatric asthma

小儿哮喘的多基因多基因风险评分

2022-11-0119
OAAI
The reckoning: The return of genomic results to 1444 participants across the eMERGE3 Network

清算: 通过eMERGE3网络将基因组结果返回给1444参与者

2022-05-0112
OAAI
Clinical Pharmacogenetics Implementation Consortium Guideline for CYP2D6, OPRM1, and COMT Genotypes and Select Opioid Therapy
2021-02-09249
OAAI
Participant choices for return of genomic results in the eMERGE Network
2020-11-0125
OAAI